Tumor microenvironment and lymphocyte infiltration (Q38001321)

26 August 2017

title

Tumor microenvironment and lymphocyte infiltration (English)

1 reference

26 August 2017

0 references

2

Muriel Moser

1 reference

26 August 2017

Gwendoline Rahir

1

1 reference

26 August 2017

publication date

10 April 2012

1 reference

Cancer Immunology, Immunotherapy

26 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

26 August 2017

volume

61

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

751-759

1 reference

Effector memory T cells, early metastasis, and survival in colorectal cancer

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

The anticancer immune response: indispensable for therapeutic success?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

A role for VEGF as a negative regulator of pericyte function and vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Metabolism, migration and memory in cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Early detection of tumor cells by innate immune cells leads to T(reg) recruitment through CCL22 production by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Random migration precedes stable target cell interactions of tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Regulation of lymph node vascular growth by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

T(H)17 cells in tumour immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

T helper 17 cells promote cytotoxic T cell activation in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-012-1253-1

10.1007/S00262-012-1253-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1005903105

0 references

1 reference